Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
NextCure Inc
NXTCCurrent price
0.44 USD
+0.0075 USD (+1.74%)
Last closed
0.41 USD
Company
www.nextcure.com
ISIN
US65343E1082
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
12 471 116 USD
Yield for 12 month
-73.77 %
1Y
3Y
5Y
10Y
15Y
NXTC
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland. Address: 9000 Virginia Manor Road, Beltsville, MD, United States, 20705
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-3 684 000 USD
Current Quarter
–
Last Quarter
–
Key Figures NXTC
1 year
3 years
5 years
10 years
EBITDA
-50 337 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-36.39 %
PEG Ratio
–
Return On Equity TTM
-63.94 %
Wall Street Target Price
3.00 USD
Revenue TTM
–
Book Value
1.99 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100.00 %
Dividend Yield
–
Gross Profit TTM
-54 199 000 USD
Earnings per share
-1.64 USD
Diluted Eps TTM
-1.64 USD
Most Recent Quarter
I 2025
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NXTC
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History NXTC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio TTM
–
Last Split Date
–
Stock Valuation NXTC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.62
Price Sales TTM
9.52
Enterprise Value EBITDA
0.51
Price Book MRQ
0.22
Financials NXTC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NXTC
For 52 weeks
0.22 USD
1.82 USD
50 Day MA
0.48 USD
Shares Short Prior Month
35 771
200 Day MA
1.01 USD
Short Ratio
0.68
Shares Short
182 944
Short Percent
0.67 %
BeatStart